Join Growin Stock Community!

安克4188.TW Overview

TW StockBiotech. & Medical
(No presentation for 4188)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

安克（4188）Overall Performance

安克（4188）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

安克（4188） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

安克（4188）Key Information

安克（4188）Profile

AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases, such as thyroid cancers, fatty liver, liver fibrosis, and obstructive sleep apnea. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-CA, a software device for analyzing digital cytological images; AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UV, a software device for quantifying and classifying the ultrasonic color intensity data acquired from FDA-cleared ultrasound systems and displaying the noise-reduced color-coded pulsatile signals. The company was incorporated in 2008 and is based in Taipei City, Taiwan.

安克（4188）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
32.93%
Net Margin
-183.06%
Revenue Growth (YoY)
-42.69%
Profit Growth (YoY)
-69.57%
3-Year Revenue Growth
-28.39%
3-Year Profit Growth
-82.62%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
32.93%
Net Margin
-183.06%
Revenue Growth (YoY)
-42.69%
Profit Growth (YoY)
-69.57%
3-Year Revenue Growth
-28.39%
3-Year Profit Growth
-82.62%
default symbol

4188

安克

13.75D

1.09%

(0.01)

  • When is 4188's latest earnings report released?

    The most recent financial report for 安克 (4188) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4188's short-term business performance and financial health. For the latest updates on 4188's earnings releases, visit this page regularly.

  • What is the operating profit of 4188?

    According to the latest financial report, 安克 (4188) reported an Operating Profit of -26.35M with an Operating Margin of -520.16% this period, representing a decline of 160.67% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4188's revenue growth?

    In the latest financial report, 安克 (4188) announced revenue of 5.07M, with a Year-Over-Year growth rate of -72.08%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4188 have?

    At the end of the period, 安克 (4188) held Total Cash and Cash Equivalents of 24.6M, accounting for 0.04 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4188 go with three margins increasing?

    In the latest report, 安克 (4188) did not achieve the “three margins increasing” benchmark, with a gross margin of 0.93%%, operating margin of -520.16%%, and net margin of -362.94%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4188's profit trajectory and future growth potential.

  • Is 4188's EPS continuing to grow?

    According to the past four quarterly reports, 安克 (4188)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.22. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4188?

    安克 (4188)'s Free Cash Flow (FCF) for the period is 493K, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 99.48% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.